Literature DB >> 193697

Effect of indomethacin on the renal actions of theophylline.

E Oliw, E Anggård, B B Fredholm.   

Abstract

The effects of theophylline ethylenediamine (15 mg/kg i.v.) on plasma renin activity (PRA), diuresis, creatinine clearance and plasma and urinary adenosine 3',5'-monophosphate (cyclic AMP) concentrations were studied in urethane-anaesthetized rabbits with and without pretreatment with indomethacin (5 mg/kg i.v.). Theophylline induced a several-fold increase in urinary sodium and water excretion, raised PRA from 76 +/- 15 TO 239 +/- 83 (S.E.M) ng/ml/h (p less than 0.05) and increased urinary cyclic AMP excretion from 0.21 +/- 0.04 to 0.50 +/- 0.08 nmol/min/kg/kidney (p less than 0.05) without any change in arterial plasma cyclic AMP concentration. The ratio between the clearance of creatinine and cyclic AMP was unchanged. After indomethacin pretreatment the theophylline-induced natriuresis was significantly reduced (p less than 0.05), while the effects of theophylline on PRA and urinary cyclic AMP excretion were unchanged. Under the present experimental conditions, indomethacin reduces renal prostaglandin biosynthesis by over 95%. our results indicate that prostaglandins might be concerned with the natriuretic effects of theophylline but not with the effect on PRA.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 193697     DOI: 10.1016/0014-2999(77)90154-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

Review 1.  Aspirin, paracetamol and non-steroidal anti-inflammatory drugs. A comparative review of side effects.

Authors:  P D Fowler
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Sep-Oct

Review 2.  Methylxanthines and the kidney.

Authors:  Hartmut Osswald; Jürgen Schnermann
Journal:  Handb Exp Pharmacol       Date:  2011

Review 3.  Theophylline poisoning. Pharmacological considerations and clinical management.

Authors:  P Gaudreault; J Guay
Journal:  Med Toxicol       Date:  1986 May-Jun

4.  Enhanced prostacyclin production by dipyridamole in man.

Authors:  G G Neri Serneri; G Masotti; L Poggesi; G Galanti; A Morettini
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.